VR for Patients With Chronic Pain (Wait & Work)
- Conditions
- Chronic Pain
- Interventions
- Device: VR (Reducept)
- Registration Number
- NCT06312735
- Lead Sponsor
- University of Twente
- Brief Summary
This cluster-RCT evaluates the effect of therapeutic virtual reality (VR) on patients with chronic musculoskeletal pain (CMP) who are on a waiting list to receive pain treatment. The used VR application, Reducept, offers pain education and pain management techniques. This home-based, stand-alone, immersive VR intervention was used daily for four weeks in the intervention group. The control group received standard care (no treatment). Primary outcome measure for this study was health-related quality of life, secondary outcome measures included various pain-related variables (e.g. pain self-efficacy and acceptance. Outcome variables will be measured after four weeks and follow-up after six months.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 53
- aged 18 years or older
- suffering from primary or secondary CMP
- finished with biomedical diagnostics and treatment
- open to biopsychosocial treatment
- willing and capable of complying with study procedures.
- not able to finish the VR intervention due to physical (e.g. visual impairment), mental (e.g. severe sensitivity to stimuli) or practical problems (e.g. insufficient tech-literacy)
- unable to finish Dutch questionnaires.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intervention group VR (Reducept) Four-week, at-home VR intervention with a recommended daily use of 10-30 minutes
- Primary Outcome Measures
Name Time Method Change in quality of life measured using the short-form 12 (SF-12) Baseline, directly after the intervention, and at six months follow-up This questionnaire on quality of life scores from 12 (worst possible score) to 56 (best possible score)
- Secondary Outcome Measures
Name Time Method Change in pain intensity measured using the numeric pain rating scale (NPRS) Baseline, directly after the intervention, and at six months follow-up This questionnaire on pain intensity scores from 0 (best possible score) to 100 (worst possible score)
Change in pain catastrophizing measured using the pain catastrophizing scale (PCS) Baseline, directly after the intervention, and at six months follow-up This questionnaire on pain catastrophizing scores from 0 (best possible score) to 52 (worst possible score).
Change in pain self-efficacy measured using the pain self-efficacy questionnaire (PSEQ) Baseline, directly after the intervention, and at six months follow-up This questionnaire scores from 0 (worst possible score) to 60 (best possible score).
Change in quality of care measured using the client satisfaction questionnaire (CSQ-8) Baseline, directly after the intervention, and at six months follow-up This questionnaire scores from 8 (worst possible score) to 32 (best possible score).
Change in pain acceptance measured using the chronic pain acceptance questionnaire (CPAQ-8) Baseline, directly after the intervention, and at six months follow-up This questionnaire scores from 0 (worst possible score) to 48 (best possible score).
Change in medication use measured using an open-ended question Baseline, directly after the intervention, and at six months follow-up This question inquires about current medication use
Change in feelings of anxiety and depression measured using the hospital anxiety and depression scale (HADS) Baseline, directly after the intervention, and at six months follow-up This questionnaire scores from 0 (worst possible score) to 42 (best possible score).
Trial Locations
- Locations (4)
Revalidatie Friesland
🇳🇱Emmeloord, Friesland, Netherlands
Deventer Ziekenhuis
🇳🇱Deventer, Overijssel, Netherlands
Roessingh rehabilitation center
🇳🇱Enschede, Overijssel, Netherlands
Nocepta
🇳🇱Hengelo, Overijssel, Netherlands